Fig. 1From: CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patientsKaplan–Meier plots for PFS and OS of sporadic EOC patients stratified by methylation markers. LogRank test was utilized for statistical evaluationBack to article page